<table>
            <tbody><tr style="FONT-SIZE: 1px">
                <td valign="top" width="5%">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top" width="95%">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2"><i>Warrants</i></font></p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2">At each of December 31, 2009 and March 31, 2009, there was an outstanding warrant to purchase 40,766 shares of common stock at an exercise price per share of $3.68 held by a former Director of the Company. The warrant expires on April 30, 2010.</font></p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2"><i>Non-Vested Stock</i></font></p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2">As of December 31, 2009, pursuant to the authorization of the Company’s Board of Directors and certain Restricted Stock Agreements, the Company had awarded 1,211,544 shares of common stock under the Company’s 2002 Plan to certain employees. Grant date fair value is determined by the market price of the Company’s common stock on the date of grant. The aggregate value of these shares at their respective grant dates amounted
                    to $2,002,276 and are recognized ratably as compensation expense over the vesting periods. The shares of common stock granted pursuant to such agreements vest in various tranches up to five years from the date of grant.</font></p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2">The shares awarded under the restricted stock agreements vest on the applicable vesting dates only to the extent the recipient of the shares is then an employee of the Company or one of its subsidiaries, and each recipient will forfeit all of the shares that have not vested on the date his or her employment is terminated.</font></p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2">As of December 31, 2009, pursuant to the authorization of the Company’s Board of Directors and certain Restricted Stock Agreements, the Company had awarded 159,767 shares of common stock that were not issued under the Company’s 2002 Plan. These shares include the award of 69,767 shares to the Company’s President. Grant date fair value is determined by the market price of the Company’s common stock on the date of
                    grant. The aggregate value of these shares at their respective grant dates amounted to $322,896 and are recognized ratably as compensation expense over a five year vesting period.</font></p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>
            </tr>

            <tr>
                <td valign="top">
                    <p align="justify">&nbsp;</p>
                </td>

                <td valign="top">
                    <p align="justify"><font size="2">A summary of all non-vested stock activity as of December 31, 2009, and changes during the nine month period then ended is presented below:</font></p>
                </td>
            </tr>
        </tbody></table>
<table>
<tbody><tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font><i>Warrants</i></font></p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font>At each of December 31, 2009 and March 31, 2009, there was an outstanding warrant to purchase 40,766 shares of common stock at an exercise price per share of $3.68 held by a former Director of the Company. The warrant expires on April 30, 2010.</font></p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font><i>Non-Vested Stock</i></font></p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font>As of December 31, 2009, pursuant to the authorization of the Company’s Board of Directors and certain Restricted Stock Agreements, the Company had awarded 1,211,544 shares of common stock under the Company’s 2002 Plan to certain employees. Grant date fair value is determined by the market price of the Company’s common stock on the date of grant. The aggregate value of these shares at their respective grant dates amounted
                    to $2,002,276 and are recognized ratably as compensation expense over the vesting periods. The shares of common stock granted pursuant to such agreements vest in various tranches up to five years from the date of grant.</font></p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font>The shares awarded under the restricted stock agreements vest on the applicable vesting dates only to the extent the recipient of the shares is then an employee of the Company or one of its subsidiaries, and each recipient will forfeit all of the shares that have not vested on the date his or her employment is terminated.</font></p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font>As of December 31, 2009, pursuant to the authorization of the Company’s Board of Directors and certain Restricted Stock Agreements, the Company had awarded 159,767 shares of common stock that were not issued under the Company’s 2002 Plan. These shares include the award of 69,767 shares to the Company’s President. Grant date fair value is determined by the market price of the Company’s common stock on the date of
                    grant. The aggregate value of these shares at their respective grant dates amounted to $322,896 and are recognized ratably as compensation expense over a five year vesting period.</font></p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p> </p>
</td>
<td>
<p><font>A summary of all non-vested stock activity as of December 31, 2009, and changes during the nine month period then ended is presented below:</font></p>
</td>
</tr>
</tbody></table>